UA106478C2 - Combination of insulin and glp-1 agonist - Google Patents

Combination of insulin and glp-1 agonist

Info

Publication number
UA106478C2
UA106478C2 UAA201106137A UAA201106137A UA106478C2 UA 106478 C2 UA106478 C2 UA 106478C2 UA A201106137 A UAA201106137 A UA A201106137A UA A201106137 A UAA201106137 A UA A201106137A UA 106478 C2 UA106478 C2 UA 106478C2
Authority
UA
Ukraine
Prior art keywords
glp
insulin
agonist
combination
drug
Prior art date
Application number
UAA201106137A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ульрих ВЕРНЕР
Original Assignee
Санофи-Авентис Дойчланд Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Авентис Дойчланд Гмбх filed Critical Санофи-Авентис Дойчланд Гмбх
Priority claimed from PCT/EP2009/063195 external-priority patent/WO2010043566A2/en
Publication of UA106478C2 publication Critical patent/UA106478C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

The invention relates to a drug comprising at least one insulin and at least one GLP-1 receptor agonist.
UAA201106137A 2008-10-17 2009-10-09 Combination of insulin and glp-1 agonist UA106478C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008051834A DE102008051834A1 (en) 2008-10-17 2008-10-17 Drug, useful e.g. for treating diabetes, preferably type-I or II and for controlling fasting, postprandial and/or postabsorptive plasma glucose concentration, comprises insulin and glucagon-like peptide-1 agonist
PCT/EP2009/063195 WO2010043566A2 (en) 2008-10-17 2009-10-09 Combination of an insulin and a glp-1 agonist

Publications (1)

Publication Number Publication Date
UA106478C2 true UA106478C2 (en) 2014-09-10

Family

ID=42034871

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201106137A UA106478C2 (en) 2008-10-17 2009-10-09 Combination of insulin and glp-1 agonist

Country Status (2)

Country Link
DE (1) DE102008051834A1 (en)
UA (1) UA106478C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2750699T3 (en) * 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Pharmaceutical combination for use in glycemic control in diabetes type 2 patients

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (en) 1988-05-11 1988-05-11 Novo Industri As NEW PEPTIDES
DE3837825A1 (en) 1988-11-08 1990-05-10 Hoechst Ag NEW INSULIN DERIVATIVES, THEIR USE AND A PHARMACEUTICAL PREPARATION CONTAINING THEM
AU641631B2 (en) 1988-12-23 1993-09-30 Novo Nordisk A/S Human insulin analogues
NZ232375A (en) 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
DK155690D0 (en) 1990-06-28 1990-06-28 Novo Nordisk As NEW PEPTIDES
US5424286A (en) 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
ATE417622T1 (en) 1996-08-08 2009-01-15 Amylin Pharmaceuticals Inc REGULATION OF GASTROINTESTINAL MOBILITY
ATE356830T1 (en) 1996-08-30 2007-04-15 Novo Nordisk As GLP-1 DERIVATIVES
WO1998030231A1 (en) 1997-01-07 1998-07-16 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the reduction of food intake
DE19726167B4 (en) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, process for its preparation and pharmaceutical preparation containing it
EP1019077B2 (en) 1997-08-08 2010-12-22 Amylin Pharmaceuticals, Inc. Novel exendin agonist compounds
EP1066314B1 (en) 1997-11-14 2007-12-26 Amylin Pharmaceuticals, Inc. Novel exendin agonist compounds
BR9814189A (en) 1997-11-14 2000-10-03 Amylin Pharmaceuticals Inc "exendin agonist compounds"
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
AU2003243929B2 (en) 2002-07-04 2009-06-04 Zp Holding Spv K/S GLP-1 and methods for treating diabetes
PL377591A1 (en) 2002-10-02 2006-02-06 Zealand Pharma A/S Stabilized exendin-4 compounds
DE102008003568A1 (en) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh New insulin analogs useful for treating diabetes
DE102008003566A1 (en) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh New insulin analogs useful for treating diabetes

Also Published As

Publication number Publication date
DE102008051834A1 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
TN2011000160A1 (en) Combination of an insulin and a glp -1 agonist
TN2012000216A1 (en) Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
EP2047252A4 (en) Structure of the insulin receptor ectodomain
EP2299989A4 (en) Stabilized transdermal drug delivery system
EP2253348A4 (en) Medication administering device
SI2307079T1 (en) Medicament delivery device
HK1151999A1 (en) Medication delivery device
HK1153155A1 (en) Medication delivery device
IL218919A0 (en) Drug delivery device with clearance compensation means
IL206927A0 (en) Drug delivery system with stabilising effect
UA106478C2 (en) Combination of insulin and glp-1 agonist
MY161655A (en) Unit dosage of apadenoson
GB0809760D0 (en) Transdermal drug delivery wristband